The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
Open accessAbstract
The aryl hydrocarbon receptor (AHR) is highly expressed in multiple organs and tissues, and there is increasing evidence that the AHR plays an important role in cellular homeostasis and disease. The AHR is expressed in multiple tumor types, in cancer cell lines, and in tumors from animal models, and the function of the AHR has been determined by RNA interference, overexpression, and inhibition studies. With few exceptions, knockdown of the AHR resulted in decreased proliferation and/or invasion and migration of cancer cell lines, and in vivo studies in mice overexpressing the constitutively active AHR exhibited enhanced stomach and liver cancers, suggesting a pro-oncogenic role for the AHR. In contrast, loss of the AHR in transgenic mice that spontaneously develop colonic tumors and in carcinogen-induced liver tumors resulted in increased carcinogenesis, suggesting that the receptor may exhibit antitumorigenic activity prior to tumor formation. AHR ligands also either enhanced or inhibited tumorigenesis, and these effects were highly tumor specific, demonstrating that selective AHR modulators that exhibit agonist or antagonist activities represent an important new class of anticancer agents that can be directed against multiple tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Poland, A., & Knutson, J. C. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.002505 · Cited by 2,515
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J., & Bradfield, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903670 · Cited by 1,601
Poland, A., Glover, E., & Kende, A. S. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33205-2 · Cited by 1,370
Nebert, D. W., Dalton, T. P., Okey, A. B., & Gonzalez, F. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400004200 · Cited by 1,182
INDUCTION OF CYTOCHROME P4501A1
Whitlock, J. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.103 · Cited by 1,124
Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1995) · Science · doi:10.1126/science.7732381 · Cited by 1,075
Self-citationKociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber, D. A., Kalnins, R. P., Frauson, L. E., Park, C. N., Barnard, S. D., et al. (1978) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(78)90075-3 · Cited by 1,057
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
Boitano, A. E., Wang, J., Romeo, R., Bouchez, L. C., Parker, A. E., Sutton, S. E., Walker, J. R., Flaveny, C. A., Perdew, G. H., Denison, M. S., et al. (2010) · Science · doi:10.1126/science.1191536 · Cited by 1,047
The PAS Superfamily: Sensors of Environmental and Developmental Signals
Gu, Y.-Z., Hogenesch, J. B., & Bradfield, C. A. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.519 · Cited by 1,029
Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., & Bradfield, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6731 · Cited by 891
Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0210 · Cited by 836
Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.
Burbach, K. M., Poland, A., & Bradfield, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8185 · Cited by 831
Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
Li, Y., Innocentin, S., Withers, D. R., Roberts, N. A., Gallagher, A. R., Grigorieva, E. F., Wilhelm, C., & Veldhoen, M. (2011) · Cell · doi:10.1016/j.cell.2011.09.025 · Cited by 820
Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles
Kiss, E. A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., & Diefenbach, A. (2011) · Science · doi:10.1126/science.1214914 · Cited by 801
Lee, J. S., Cella, M., McDonald, K. G., Garlanda, C., Kennedy, G. D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C. A., Newberry, R. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2187 · Cited by 777
Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., & Zhao, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr218 · Cited by 748
Band Horwitz, S. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90048-b · Cited by 740
Apetoh, L., Quintana, F. J., Pot, C., Joller, N., Xiao, S., Kumar, D., Burns, E. J., Sherr, D. H., Weiner, H. L., & Kuchroo, V. K. (2010) · Nature Immunology · doi:10.1038/ni.1912 · Cited by 725
Safe, S. H. (1986) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.26.040186.002103 · Cited by 710
Self-citationNguyen, N. T., Kimura, A., Nakahama, T., Chinen, I., Masuda, K., Nohara, K., Fujii-Kuriyama, Y., & Kishimoto, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014465107 · Cited by 685
DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 634
Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., et al. (1997) · Genes to Cells · doi:10.1046/j.1365-2443.1997.1490345.x · Cited by 626
Katzenellenbogen, J. A. (1996) · Molecular Endocrinology · doi:10.1210/me.10.2.119 · Cited by 535
Gandhi, R., Kumar, D., Burns, E. J., Nadeau, M., Dake, B., Laroni, A., Kozoriz, D., Weiner, H. L., & Quintana, F. J. (2010) · Nature Immunology · doi:10.1038/ni.1915 · Cited by 476
The aryl hydrocarbon receptor: studies using the AHR-null mice.
Gonzalez, F. J., & Fernández‐Salguero, P. M. (1998) · PubMed · Cited by 448
The aryl hydrocarbon receptor in immunity
Esser, C., Rannug, A., & Stockinger, B. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.005 · Cited by 447
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system
Stevens, E. A., Mezrich, J. D., & Bradfield, C. A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03054.x · Cited by 413
The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways
Puga, A., Ma, C., & Marlowe, J. L. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.031 · Cited by 410
cDNA cloning and structure of mouse putative Ah receptor
Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, O., Funae, Y., & Fujii-Kuriyama, Y. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91185-s · Cited by 403
The aryl hydrocarbon receptor, more than a xenobiotic‐interacting protein
Barouki, R., Coumoul, X., & Fernandez-Salguero, P. M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.046 · Cited by 398
Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., & Bradfield, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190256997 · Cited by 377
Safe, S., & Kim, K. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0103 · Cited by 368
Self-citationKolluri, S. K., Weiss, C., Koff, A., & Gottlicher, M. (1999) · Genes & Development · doi:10.1101/gad.13.13.1742 · Cited by 364
Lesions of Aryl-hydrocarbon Receptor–deficient Mice
Fernandez-Salguero, P. M., Ward, J. M., Sundberg, J. P., & Gonzalez, F. J. (1997) · Veterinary Pathology · doi:10.1177/030098589703400609 · Cited by 352
Inhibitory Aryl Hydrocarbon Receptor−Estrogen Receptor α Cross-Talk and Mechanisms of Action
Safe, S., & Wormke, M. (2003) · Chemical Research in Toxicology · doi:10.1021/tx034036r · Cited by 348
Self-citationCloning and expression of a human Ah receptor cDNA.
Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., & Bradfield, C. A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13282-3 · Cited by 348
Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2
Köhle, C., & Bock, K. W. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.009 · Cited by 342
Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R., & Safe, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1843-1855.2003 · Cited by 325
Self-citationSelective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer
Jordan, V. C., & O'Malley, B. W. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3886 · Cited by 324
Polychlorinated Dibenzo-Para-Dioxins and Polychlorinated Dibenzofurans.
(1997) · PubMed · Cited by 322
Puga, A., Barnes, S. J., Dalton, T. P., Chang, C.-Y., Knudsen, E. S., & Maier, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2943 · Cited by 316
CH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) Receptor
Zhao, B., DeGroot, D. E., Hayashi, A., He, G., & Denison, M. S. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq217 · Cited by 312
A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors
Andersson, P., McGuire, J., Rubio, C., Gradin, K., Whitelaw, M. L., Pettersson, S., Hanberg, A., & Poellinger, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152706299 · Cited by 310
Kim, S.-H., Henry, E. C., Kim, D.-K., Kim, Y.-H., Shin, K. J., Han, M. S., Lee, T. G., Kang, J.-K., Gasiewicz, T. A., Ryu, S. H., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021832 · Cited by 286
Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane
Chen, I. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1631 · Cited by 285
Singh, N. P., Singh, U. P., Singh, B., Price, R. L., Nagarkatti, M., & Nagarkatti, P. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023522 · Cited by 284
Ma, Q., & Whitlock, J. P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2144 · Cited by 273
Kawajiri, K., Kobayashi, Y., Ohtake, F., Ikuta, T., Matsushima, Y., Mimura, J., Pettersson, S., Pollenz, R. S., Sakaki, T., Hirokawa, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902132106 · Cited by 265
A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein
Ge, N.-L., & Elferink, C. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22708 · Cited by 258
Intrinsic Function of the Aryl Hydrocarbon (Dioxin) Receptor as a Key Factor in Female Reproduction
Baba, T., Mimura, J., Nakamura, N., Harada, N., Yamamoto, M., Morohashi, K.-I., & Fujii-Kuriyama, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10040-10051.2005 · Cited by 256
Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse
Nebert, D. W., Robinson, J. R., Niwa, A., Kumari, K., & Poland, A. P. (1975) · Journal of Cellular Physiology · doi:10.1002/jcp.1040850407 · Cited by 247
Spink, D. C., Eugster, H.-P., Lincoln, D. W., Schuetz, J. D., Schuetz, E. G., Johnson, J. A., Kaminsky, L. S., & Gierthy, J. F. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90404-k · Cited by 244
Krishnan, V., Wang, X., & Safe, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40767-8 · Cited by 243
Self-citationA Constitutively Active Dioxin/Aryl Hydrocarbon Receptor Promotes Hepatocarcinogenesis in Mice
Moennikes, O., Loeppen, S., Buchmann, A., Andersson, P., Ittrich, C., Poellinger, L., & Schwarz, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0875 · Cited by 228
Hu, W., Sorrentino, C., Denison, M. S., Kolaja, K., & Fielden, M. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032748 · Cited by 225
Adverse Reproductive Outcomes in the Transgenic Ah Receptor-Deficient Mouse
Abbott, B. D., Schmid, J. E., Pitt, J. A., Buckalew, A. R., Wood, C. R., Held, G. A., & Diliberto, J. J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8601 · Cited by 219
Funatake, C. J., Marshall, N. B., Steppan, L. B., Mourich, D. V., & Kerkvliet, N. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4184 · Cited by 218
Matthews, J., Wihlén, B., Thomsen, J., & Gustafsson, J.-Å. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5317-5328.2005 · Cited by 210
Physiological Role of the Aryl Hydrocarbon Receptor in Mouse Ovary Development
Benedict, J. C. (2000) · Toxicological Sciences · doi:10.1093/toxsci/56.2.382 · Cited by 209
Beischlag, T. V., & Perdew, G. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500090200 · Cited by 203
Krishnan, V., Porter, W., Santostefano, M., Wang, X., & Safe, S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6710 · Cited by 203
Self-citationMarshall, N. B., & Kerkvliet, N. I. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05125.x · Cited by 195
Dioxin and cancer: a critical review
Cole, P., Trichopoulos, D., Pastides, H., Starr, T., & Mandel, J. S. (2003) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2003.08.002 · Cited by 195
Role of the aryl hydrocarbon receptor in cell cycle regulation
Puga, A., Xia, Y., & Elferink, C. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00069-8 · Cited by 192
Spink, D. C., Lincoln, D. W., Dickerman, H. W., & Gierthy, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6917 · Cited by 186
Krishnan, V., & Safe, S. (1993) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1993.1086 · Cited by 184
Self-citationRomkes, M., Piskorska-Pliszczynska, J., & Safe, S. (1987) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(87)90292-4 · Cited by 183
Self-citationThe Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems
McMillan, B. J., & Bradfield, C. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037259 · Cited by 177
The Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis
Fan, Y., Boivin, G. P., Knudsen, E. S., Nebert, D. W., Xia, Y., & Puga, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3090 · Cited by 177
Weiß, C., Kolluri, S. K., Kiefer, F., & Göttlicher, M. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0214 · Cited by 170
Carcinogenicity of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin in experimental models
Knerr, S., & Schrenk, D. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600006 · Cited by 168
Abdelrahim, M., Smith, R., & Safe, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1373 · Cited by 168
Self-citationLahvis, G. P., Pyzalski, R. W., Glover, E., Pitot, H. C., McElwee, M. K., & Bradfield, C. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008888 · Cited by 168
The Kynurenine Pathway in Brain Tumor Pathogenesis
Adams, S., Braidy, N., Bessesde, A., Brew, B. J., Grant, R., Teo, C., & Guillemin, G. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0549 · Cited by 159
Marlowe, J. L., Knudsen, E. S., Schwemberger, S., & Puga, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404315200 · Cited by 158
Immunological Effects of Chlorinated Dibenzo-p-Dioxins
Kerkvliet, N. I. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s947 · Cited by 157
Diry, M., Tomkiewicz, C., Köhle, C., Coumoul, X., Bock, K. W., Barouki, R., & Transy, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209553 · Cited by 157
Differential Recruitment of Coactivator RIP140 byAh and Estrogen Receptors
Kumar, M. B., Tarpey, R. W., & Perdew, G. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22155 · Cited by 157
Prenatal TCDD and predisposition to mammary cancer in the rat
Brown, N. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1623 · Cited by 155
Jaffrain‐Rea, M., Angelini, M., Gargano, D., Tichomirowa, M. A., Daly, A., Vanbellinghen, J.-F., D'Innocenzo, E., Barlier, A., Giangaspero, F., Esposito, V., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0094 · Cited by 153
Goldstein, J. A., & Safe, S. H. (1989) · Elsevier eBooks · doi:10.1016/b978-0-444-81029-8.50013-8 · Cited by 151
Self-citationKadow, S., Jux, B., Zahner, S. P., Wingerath, B., Chmill, S., Clausen, B. E., Hengstler, J. G., & Esser, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100912 · Cited by 150
Nguyen, T. A., Hoivik, D. J., Lee, J., & Safe, S. H. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1282 · Cited by 148
Self-citationBarhoover, M. A., Hall, J. M., Greenlee, W. F., & Thomas, R. S. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059675 · Cited by 144
Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
Prud’homme, G. J., Glinka, Y., Toulina, A., Ace, O., Subramaniam, V., & Jothy, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013831 · Cited by 143
Lund, A. K., Goens, M. B., Kanagy, N. L., & Walker, M. K. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.08.008 · Cited by 142
Gramatzki, D., Pantazis, G., Schittenhelm, J., Tabatabai, G., Köhle, C., Wick, W., Schwarz, M., Weller, M., & Tritschler, I. (2009) · Oncogene · doi:10.1038/onc.2009.104 · Cited by 140
Gasiewicz, T. A., & Rucci, G. (1991) · PubMed · Cited by 135
Gillesby, B. E., Stanostefano, M., Porter, W. W., Safe, S. H., Wu, Z.-F., & Zacharewski, T. R. (1997) · Biochemistry · doi:10.1021/bi962131b · Cited by 135
Self-citationKoliopanos, A., Kleeff, J. H., Xiao, Y., Safe, S. H., Zimmermann, A., Büchler, M. W., & Friess, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205633 · Cited by 133
Self-citationThe aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway
Tomkiewicz, C., Herry, L., Bui, L.-C., Metayer, C., Bourdeloux, M., Barouki, R., & Coumoul, X. (2012) · Oncogene · doi:10.1038/onc.2012.197 · Cited by 132
Maximal Aryl Hydrocarbon Receptor Activity Depends on an Interaction with the Retinoblastoma Protein
Elferink, C. J., Ge, N.-L., & Levine, A. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.664 · Cited by 131
Tan, K. P., Wang, B., Yang, M., Boutros, P. C., MacAulay, J., Xu, H., Chuang, A. I., Kosuge, K., Yamamoto, M., Takahashi, S., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065078 · Cited by 130
Hollingshead, B. D., Beischlag, T. V., DiNatale, B. C., Ramadoss, P., & Perdew, G. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6168 · Cited by 128
Zacharewski, T. R., Bondy, K. L., McDonell, P. J., & Wu, Z.-F. (1994) · PubMed · Cited by 125
Hall, J. M., Barhoover, M. A., Kazmin, D. A., McDonnell, D. P., Greenlee, W. F., & Thomas, R. S. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0346 · Cited by 123
Schmidt, J. V., Carver, L. A., & Bradfield, C. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80668-1 · Cited by 120
Bock, K. W., & Köhle, C. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.004 · Cited by 119
Wormke, M., Stoner, M. A., Saville, B., & Safe, S. H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01830-5 · Cited by 118
Self-citationJana, N. R., Sarkar, S., Ishizuka, M., Yonemoto, J., Tohyama, C., & Sone, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0367 · Cited by 116
Singh, K. P., Garrett, R. W., Casado, F. L., & Gasiewicz, T. A. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0333 · Cited by 114
Identification of a High-Affinity Ligand That Exhibits Complete Aryl Hydrocarbon Receptor Antagonism
Smith, K. J., Murray, I. A., Tanos, R., Tellew, J. E., Boitano, A. E., Bisson, W. H., Kolluri, S. K., Cooke, M. P., & Perdew, G. H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178392 · Cited by 113
Duan, R., Porter, W. W., Samudio, I. J., Vyhlidal, C. A., Kladde, M. P., & Safe, S. H. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.9.0338 · Cited by 113
Self-citationSERMs: Meeting the Promise of Multifunctional Medicines
Jordan, V. C. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk062 · Cited by 112
Gierthy, J. F., LINCOLN, D. W., Gillespie, M. B., Seeger, J. I., MARTINEZ, H. L., Dickerman, H. W., & Kumar, S. A. (1987) · PubMed · Cited by 112
Kumar, M. B., & Perdew, G. H. (1999) · Europe PMC (PubMed Central) · Cited by 111
Degner, S. C., Papoutsis, A. J., Selmin, O. I., & Romagnolo, D. F. (2008) · Journal of Nutrition · doi:10.3945/jn.108.099259 · Cited by 110
Villano, C. M., Murphy, K. A., Akintobi, A., & WHITE, L. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.05.001 · Cited by 108
Mulero‐Navarro, S., Pozo‐Guisado, E., Pérez-Mancera, P. A., Alvarez, A. M., Catalina‐Fernández, I., Hernández‐Nieto, E., Sáenz‐Santamaría, J., Martínez, N., Rojas, J. M., Sánchez-García, I., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504538200 · Cited by 107
Multiple Mechanisms Are Involved in Ah Receptor-Mediated Cell Cycle Arrest
Huang, G., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002410 · Cited by 104
Xie, G., Peng, Z., & Raufman, J. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00427.2011 · Cited by 103
In Vivo Induction of Tr1 Cells via Mucosal Dendritic Cells and AHR Signaling
Wu, H. Y., Quintana, F. J., da Cunha, A. P., Dake, B. T., Koeglsperger, T., Starossom, S. C., & Weiner, H. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023618 · Cited by 102
Rüegg, J., Swedenborg, E., Wahlström, D., Escande, A., Balaguer, P., Pettersson, K., & Pongratz, I. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0128 · Cited by 102
Marshall, N. B., Vorachek, W. R., Steppan, L. B., Mourich, D. V., & Kerkvliet, N. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2382 · Cited by 100
Zhang, S., Kim, K., Jin, U. H., Pfent, C. M., Cao, H., Amendt, B. A., Liu, X., Wilson-Robles, H. M., & Safe, S. H. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0548 · Cited by 100
Self-citationJin, U.-H., Lee, S., & Safe, S. H. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.195339 · Cited by 97
Self-citationJordan, V. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0029 · Cited by 97
Barnes, S., Knudsen, K. E., & Puga, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000356 · Cited by 95
Benedict, J. C., Miller, K. P., Lin, T.-M., Greenfeld, C. R., Babus, J. K., Peterson, R. E., & Flaws, J. A. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.007492 · Cited by 93
The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
Zhang, S. J., Lei, P., Liu, X., Li, X., Walker, K., Kotha, L., Rowlands, C., & Safe, S. H. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0054 · Cited by 93
Self-citationLoaiza‐Perez, A., Kenney, S., Boswell, J. L., Hollingshead, M. G., Alley, M. C., Hose, C. D., Ciolino, H. P., Yeh, G. C., Trepel, J. B., Vistica, D. T., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.715.3.6 · Cited by 93
Hockings, J. K., Thorne, P. A., Kemp, M. Q., Morgan, S. S., Selmin, O. I., & Romagnolo, D. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1619 · Cited by 90
Santostefano, M. J., Merchant, M., Arellano, L. A. D. L. P., Morrison, V. M., Denison, M. S., & Safe, S. H. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13600-6 · Cited by 90
Self-citationPeng, T., Chen, J., Mao, W., Song, X., & Chen, M. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-27 · Cited by 88
Yang, X., Liu, D., Murray, T. J., Mitchell, G. C., Hestermann, E. V., Karchner, S. I., Merson, R. R., Hahn, M. E., & Sherr, D. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208938 · Cited by 86
Wormke, M., Castro‐Rivera, E., Chen, I., & Safe, S. H. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00030-3 · Cited by 85
Self-citationShimba, S., Komiyama, K., Moro, I., & Tezuka, M. (2002) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003289 · Cited by 85
Levine, A., Chen, L., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.461 · Cited by 84
Chesire, D. R., Dunn, T. A., Ewing, C. M., Luo, J., & Isaacs, W. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3309 · Cited by 84
Bunaciu, R. P., & Yen, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2299 · Cited by 84
Ahmed, S., Valen, E., Sandelin, A., & Matthews, J. B. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp144 · Cited by 83
Vogel, C. F. A., Li, W., Sciullo, E. M., Newman, J. W. I., Hammock, B. D., Reader, J. R., Tuscano, J. M., & Matsumura, F. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070406 · Cited by 83
Williams, S. P., Nowicki, M. O., Liu, F., Press, R., Godlewski, J. A., Abdel‐Rasoul, M., Kaur, B., Fernández, S., Chiocca, E. A., & Lawler, S. E. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3026 · Cited by 82
The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells
O’Donnell, E. F., Kopparapu, P., Koch, D. C., Jang, H. S., Phillips, J. L., Tanguay, R. L., Kerkvliet, N. I., & Kolluri, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040926 · Cited by 81
Wang, W., Smith, R., & Safe, S. H. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0782 · Cited by 81
Self-citationMorrow, D., Qin, C., Smith, R., & Safe, S. H. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.10.005 · Cited by 80
Self-citationTompkins, L. M., Li, H., Li, L., Lynch, C., Xie, Y., Nakanishi, T., Ross, D. D., & Wang, H. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.016 · Cited by 77
Sauzeau, V., Carvajal-González, J. M., Riolobos, A. S., Sevilla, M. A., Menacho-Márquez, M., Román, Á., Abad, A., Montero, M. J., Fernández‐Salguero, P. M., & Bustelo, X. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187534 · Cited by 77
Lund, A. K., Goens, M. B., Nuñez, B. A., & Walker, M. K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.07.005 · Cited by 77
Wang, F., Samudio, I. J., & Safe, S. H. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00379-8 · Cited by 76
Self-citationAh Receptor Antagonism Represses Head and Neck Tumor Cell Aggressive Phenotype
DiNatale, B. C., Smith, K. M., John, K., Gowda, K., Amin, S., & Perdew, G. H. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0216 · Cited by 73
McDougal, A. J., Wilson, C., & Safe, S. H. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00299-1 · Cited by 72
Self-citationSubstituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists
Lu, Y.-F., Santostefano, M. J., Cunningham, B. D. M., Threadgill, M. D., & Safe, S. H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00063-9 · Cited by 71
Self-citationIto, T., Tsukumo, S., Suzuki, N., Motohashi, H., Yamamoto, M. P., Fujii‐Kuriyama, Y., Mimura, J., Lin, T.-M., Peterson, R. E., Tohyama, C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402143200 · Cited by 70
Jin, G., Moore, A. J., Head, J. L., Neumiller, J. J., & Lawrence, B. P. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq153 · Cited by 69
DiNatale, B. C., Schroeder, J. C., & Perdew, G. H. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20702 · Cited by 68
Porter, W. W., Wang, F., Duan, R., Qin, C., Castro‐Rivera, E., Kim, K., & Safe, S. H. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0260031 · Cited by 68
Self-citationGenetic expression of aryl hydrocarbon hydroxylase activity in the mouse
Niwa, A., Kumaki, K., Nebert, D. W., & Poland, A. (1975) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(75)90420-8 · Cited by 67
Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer
Safe, S. H., Qin, C., & McDougal, A. J. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.9.1385 · Cited by 67
Self-citationYin, X., Chen, J., Mao, W., Wang, Y., & Chen, M. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-46 · Cited by 67
A Proposed Mechanism for the Protective Effect of Dioxin against Breast Cancer
Hsu, E. L., Yoon, D. S., Choi, H. H., Wang, F., Taylor, R. T., Chen, N., Zhang, R., & Hankinson, O. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm125 · Cited by 65
McDougal, A. J., Wormke, M., Calvin, J. A., & Safe, S. H. (2001) · PubMed · Cited by 64
Self-citationRegulation of Aryl Hydrocarbon Receptor Function by Selective Estrogen Receptor Modulators
DuSell, C. D., Nelson, E. R., Wittmann, B. M., Fretz, J. A., Kazmin, D. A., Thomas, R. S., Pike, J. W., & McDonnell, D. P. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0339 · Cited by 63
Esser, C. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0818-2 · Cited by 62
Gierthy, J. F., & Lincoln, D. W. (1988) · Breast Cancer Research and Treatment · doi:10.1007/bf01805943 · Cited by 61
Khan, S., Barhoumi, R., Burghardt, R. C., Liu, S., Kim, K., & Safe, S. H. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0100 · Cited by 60
Self-citationAryl Hydrocarbon Receptor Regulation of Ceramide-induced Apoptosis in Murine Hepatoma 1c1c7 Cells
Reiners, J. J., & Clift, R. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2502 · Cited by 59
Rogers, J. M., & Denison, M. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.6.1393 · Cited by 58
Aryl hydrocarbon exposure induces expression of MMP-9 in human prostate cancer cell lines
Haque, M., Francis, J., & Sehgal, I. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.043 · Cited by 57
Bannister, R. M., Biegel, L. B., Davis, D., Astroff, B., & Safe, S. H. (1989) · Toxicology · doi:10.1016/0300-483x(89)90040-1 · Cited by 55
Self-citationPortal‐Núñez, S., Shankavaram, U. T., Rao, M., Datrice, N., Atay, S. M., Aparicio, M., Camphausen, K. A., Fernández‐Salguero, P. M., Chang, H., Lin, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0818 · Cited by 55
Murray, I. A., Flaveny, C. A., Chiaro, C. R., Sharma, A. K., Tanos, R. S., Schroeder, J. C., Amin, S. G., Bisson, W. H., Kolluri, S. K., & Perdew, G. H. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.069369 · Cited by 53
Oculomotor Deficits in Aryl Hydrocarbon Receptor Null Mouse
Chevallier, A., Mialot, A., Petit, J.-M., Fernández‐Salguero, P. M., Barouki, R., Coumoul, X., & Beraneck, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053520 · Cited by 52
AhR deficiency impairs expression of LPS-induced inflammatory genes in mice
Wu, D., Li, W., Lok, P., Matsumura, F., & Vogel, C. F. A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.018 · Cited by 52
Moore, M., Wang, X., Lu, Y.-F., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32636-4 · Cited by 51
Labrecque, M. P., Takhar, M., Hollingshead, B. D., Préfontaine, G. G., Perdew, G. H., & Beischlag, T. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029545 · Cited by 50
Funatake, C. J., Marshall, N. B., & Kerkvliet, N. I. (2008) · Journal of Immunotoxicology · doi:10.1080/15476910802019037 · Cited by 49
Madak‐Erdogan, Z., & Katzenellenbogen, B. S. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr300 · Cited by 49
Gluschnaider, U., Hidas, G., Cojocaru, G., Yutkin, V., Ben‐Neriah, Y., & Pikarsky, E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009060 · Cited by 48
Dioxin Exposure Disrupts the Differentiation of Mouse Embryonic Stem Cells into Cardiomyocytes
Wang, Y., Fan, Y., & Puga, A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfq038 · Cited by 47
Ambolet-Camoit, A., Bui, L. C., Pierre, S., Chevallier, A., Marchand, A., Coumoul, X., Garlatti, M., Andréau, K., Barouki, R., & Aggerbeck, Μ. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq082 · Cited by 45
Yao, C., & Safe, S. H. (1989) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(89)90307-4 · Cited by 45
Self-citationThe AH Receptor in Biology and Toxicology
Pohjanvirta, R. (2011) · Cited by 44
Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells
Zhao, S., Kanno, Y., Nakayama, M., Makimura, M., Ohara, S., & Inouye, Y. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.025 · Cited by 44
Subramaniam, V., Ace, O., Prud’homme, G. J., et al. (2010) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.10.012 · Cited by 42
Aguilera‐Montilla, N., Chamorro, S., Nieto, C., Sánchez‐Cabo, F., Dopazo, A., Fernández‐Salguero, P. M., Rodríguez‐Fernández, J. L., Pello, Ó. M., Andrés, V., Cuenda, A., et al. (2013) · Blood · doi:10.1182/blood-2012-07-445106 · Cited by 42
Jana, N. R., Sarkar, S., Ishizuka, M., Yonemoto, J., Tohyama, C., & Sone, H. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2001.0275 · Cited by 41
Wang, X., Thomsen, J. S., Santostefano, M. J., Rosengren, R. J., Safe, S. H., & Perdew, G. H. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/s0922-4106(05)80044-6 · Cited by 41
Self-citationThe Aryl Hydrocarbon Receptor Contributes to the Proliferation of Human Medulloblastoma Cells
Dever, D. P., & Opanashuk, L. A. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.077305 · Cited by 41
Molecular Characterization of the Murine Ahr Gene
Schmidt, J. V., Carver, L. A., & BradfieldS, C. A. (1993) · Cited by 39
Tran, C., Richmond, O. H., Aaron, L., & Powell, J. B. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.010 · Cited by 38
Zhou, J., & Gasiewicz, T. A. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00274-1 · Cited by 38
Funatake, C. J. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh245 · Cited by 36
Wang, T., Wyrick, K. L., Meadows, G. G., Wills, T. B., & Vorderstrasse, B. A. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr247 · Cited by 35
Kiss, E. A., & Vonarbourg, C. (2012) · Gut Microbes · doi:10.4161/gmic.21865 · Cited by 35
Gohl, G., Lehmköster, T., Münzel, P., Schrenk, D., Viebahn, R., & Bock, K. W. (1996) · Carcinogenesis · doi:10.1093/carcin/17.3.443 · Cited by 34
Wang, T., Gavin, H. M., Arlt, V. M., Lawrence, B. P., Fenton, S. E., Medina, D., & Vorderstrasse, B. A. (2010) · International Journal of Cancer · doi:10.1002/ijc.25493 · Cited by 34
FOXA1 Is Essential for Aryl Hydrocarbon Receptor–Dependent Regulation of Cyclin G2
Ahmed, S., Al-Saigh, S., & Matthews, J. B. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0502 · Cited by 34
Chuang, C.-Y., Chang, H., Lin, P., Sun, S., Chen, P., Lin, Y.-Y., Sheu, G., Ko, J., Hsu, S., & Chang, J. T. (2011) · Gene · doi:10.1016/j.gene.2011.10.019 · Cited by 33
Uric acid stones in the urinary bladder of aryl hydrocarbon receptor (AhR) knockout mice
Butler, R., Inzunza, J., Suzuki, H., Fujii‐Kuriyama, Y., Warner, M. N., & Gustafsson, J.-Α. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120581109 · Cited by 26
Kohle, C., Hassepass, I., Bock-hennig, B. S., Bock, K. W., Poellinger, L., & McGuire, J. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00076-0 · Cited by 24
Piskorska-Pliszczynska, J., Astroff, B., Zacharewski, T. R., Harris, M. A., Rosengren, R. J., Morrison, V. M., Safe, L. M., & Safe, S. H. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90283-o · Cited by 21
Self-citationSantostefano, M. J., Piskorska-Pliszczynska, J., Morrison, V. M., & Safe, S. H. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90642-a · Cited by 11
Self-citationDioxin as an Environmental Pollutant and Its Role in Breast Cancer
Safe, S. H., Walker, K., & Zhang, S. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9896-5_7 · Cited by 2
Self-citation
Cited by
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3846 · Cited by 883
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation
Hubbard, T. D., Murray, I. A., & Perdew, G. H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064246 · Cited by 640
The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology
Esser, C., & Rannug, A. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009001 · Cited by 501
Beyond the obvious: Environmental health implications of polar polycyclic aromatic hydrocarbons
Idowu, O., Semple, K. T., Ramadass, K., O'Connor, W., Hansbro, P., & Thavamani, P. (2019) · Environment International · doi:10.1016/j.envint.2018.12.051 · Cited by 387
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
Muller, A. J., Manfredi, M. G., Zakharia, Y., & Prendergast, G. C. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-018-0702-0 · Cited by 262
Metadata
- Authors
- Safe, S., Lee, S.-O., & Jin, U.-H.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-06-14
- Volume
- 135
- Issue
- 1
- Pages
- 1-16
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2103409364
- Cited by
- 264
- References
- 199
- FWCI
- 17.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.